Experimental evaluation of inhibitory effect of 10-hydroxycamptothecin on hypoxia-inducible factor-1α expression and angiogenesis in liver tumors after transcatheter arterial embolization

Journal of Vascular and Interventional Radiology

Volumn 21, Issue 10, 2010, Pages 1565-1572

  Liang, Bin ^a   Zheng, Chuansheng ^a   Feng, Gansheng ^a   Wu, Hanping ^b   Wang, Yong ^a   Zhao, Hui ^a   Li, Xin ^a   Qian, Jun ^a   Liang, Huimin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

10 HYDROXYCAMPTOTHECIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OIL; POLYVINYL ALCOHOL; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; CORRELATIONAL STUDY; EXPERIMENTAL RABBIT; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CATHETERIZATION; EMBOLIZATION, THERAPEUTIC; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RABBITS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957815559     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.05.028     Document Type: Article

References (34)

1. D.B. Brown, J.E. Gould, and D.A. Gervais Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria J Vasc Interv Radiol 18 2007 1469 1478
2. C. Breedis, and G. Young The blood supply of neoplasms in the liver Am J Pathol 30 1954 969 977
3. J. Bruix, J.M. Llovet, and A. Castells Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution Hepatology 27 1998 1578 1583
4. J.K. Lee, Y.H. Chung, and B.C. Song Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization J Gastroenterol Hepatol 17 2002 52 58
5. T.C. Liou, S.C. Shih, C.R. Kao, S.Y. Chou, S.C. Lin, and H.Y. Wang Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization J Hepatol 23 1995 563 568
6. W.J. Guo, J. Li, and W.L. Ling Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats World J Gastroenterol 8 2002 476 479
7. S. Gupta, S. Kobayashi, S. Phongkitkarun, L.D. Broemeling, and Z. Kan Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model Invest Radiol 41 2006 516 521
8. G.L. Semenza, and G.L. Wang A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation Mol Cell Biol 12 1992 5447 5454
9. T.K. Rhee, J.Y. Young, and A.C. Larson Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1α in rabbit VX2 liver tumors J Vasc Interv Radiol 18 2007 639 645
10. S. Virmani, T.K. Rhee, and R.K. Ryu Comparison of hypoxia-inducible factor-1α expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors J Vasc Interv Radiol 19 2008 1483 1489
11. A. Rapisarda, B. Uranchimeg, and D.A. Scudiero Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway Cancer Res 62 2002 4316 4324
12. A. Rapisarda, B. Uranchimeg, O. Sordet, Y. Pommier, R.H. Shoemaker, and G. Melillo Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications Cancer Res 64 2004 1475 1482
13. A. Rapisarda, J. Zalek, and M. Hollingshead Schedule-dependent inhibition of hypoxia-inducible factor-1α protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts Cancer Res 64 2004 6845 6848
14. P.L. Moreira, and Y.H. An Animal models for therapeutic embolization Cardiovasc Intervent Radiol 26 2003 100 110
15. H. Zhong, A.M. De Marzo, and E. Laughner Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases Cancer Res 59 1999 5830 5835
16. R. Yamaguchi, H. Yano, A. Iemura, S. Ogasawara, M. Haramaki, and M. Kojiro Expression of vascular endothelial growth factor in human hepatocellular carcinoma Hepatology 28 1998 68 77
17. N. Weidner, J.P. Semple, W.R. Welch, and J. Folkman Tumor angiogenesis and metastasiscorrelation in invasive breast carcinoma N Engl J Med 324 1991 1 8
18. D.E. Ramsey, L.Y. Kernagis, M.C. Soulen, and J.F. Geschwind Chemoembolization of hepatocellular carcinoma J Vasc Interv Radiol 13 2002 S211 S221
19. A.L. Harris Hypoxiaa key regulatory factor in tumour growth Nat Rev Cancer 2 2002 38 47
20. B. Liang, C. Zheng, and G. Feng Expression of hypoxia-inducible factor-1alpha in liver tumors after transcatheter arterial embolization in an animal model J Huazhong Univ Sci Technolog Med Sci 29 2009 776 781
21. K.W. Kohn, R.G. Shao, and Y. Pommier How do drug-induced topoisomerase I-DNA lesions signal to the molecular interaction network that regulates cell cycle checkpoints, DNA replication, and DNA repair? Cell Biochem Biophys 33 2000 175 180
22. H. Kamiyama, S. Takano, K. Tsuboi, and A. Matsumura Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1α)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells J Cancer Res Clin Oncol 131 2005 205 213
23. J. Torregrossa, G.J. Bubley, and G.B. Jones Microwave expedited synthesis of 5-aminocamptothecin analogs: Inhibitors of hypoxia inducible factor HIF-1α Bioorg Med Chem Lett 16 2006 6082 6085
24. W. Shi, and S. Yu Inhibitory effect of HCPT on expression of HIF-1α and downstream genes in hypoxic human cervical SiHa cancer cells J Huazhong Univ Sci Technolog Med Sci 27 2007 586 589
25. S.P. Tu, D.M. Wu, Y.Z. Yuan, Y.L. Wu, S.H. Jiang, and Y.X. Wu Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization with hydroxycamptothecin Shijie Huaren Xiaohua Zazhi 7 1999 158 160
26. Z.J. Yu, J.W. Yu, and W. Cai Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma World J Gastroenterol 11 2005 5221 5225
27. I. Serganova, M. Doubrovin, and J. Vider Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice Cancer Res 64 2004 6101 6108
28. J. Liu, R. Qu, M. Ogura, T. Shibata, H. Harada, and M. Hiraoka Real-time imaging of hypoxia-inducible factor-1 activity in tumor xenografts J Radiat Res (Tokyo) 46 2005 93 102
29. H. Jiang, Q. Meng, and H. Tan Antiangiogenic therapy enhances the efficacy of transcatheter arterial embolization for hepatocellular carcinoma Int J Cancer 121 2007 416 424
30. A. Maataoui, J. Qian, and D. Vossoughi Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model Eur Radiol 15 2005 127 133
31. H.P. Wu, G.S. Feng, H.M. Liang, C.S. Zheng, and X. Li Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats World J Gastroenterol 15 2004 813 818
32. A. Wang, and S. Li Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect BMC Biotechnol 8 2008 46 52
33. R.H. Mathijssen, W.J. Loos, J. Verweij, and A. Sparreboom Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan Curr Cancer Drug Targets 2 2002 103 123
34. E. Liapi, K.H. Lee, C.C. Georgiades, K. Hong, and J.F. Geschwind Drug-eluting particles for interventional pharmacology Tech Vasc Interv Radiol 10 2007 261 269